Skip to main content

Table 5 Therapeutic modalities in 2012 (n = 104)

From: Hereditary angioedema due to C1 - inhibitor deficiency in Switzerland: clinical characteristics and therapeutic modalities within a cohort study

Pharmacological prophylaxis

women and men

women

men

tranexamic acid

10

6 (10 %)

4 (8 %)

danazol

26

13 (23 %)

13 (27 %

IRT

   

pd C1 - INH

9

7 (12 %)

2 (4 %)

Therapy of acute attacks

   

Icatibant

12

9 (16 %)

3 (6 %)

pd C1 – INH

57

32 (56 %)

25 (53 %)

  1. Percentages are related in women to the total amount of women, in men to the total amount of men